Domov › Rak prostate › North Carolina › Durham
Klinične študije za Rak prostate v Durham, NC
32 študij za Rak prostate išče udeležence na lokacijah v Durham in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- Duke University, Durham
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Vključevanje udeležencevFaza 3
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Vključevanje udeležencevFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Durham VA Medical Center, Durham
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Vključevanje udeležencevFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
DESTINY-PANTUMOUR04
Vključevanje udeležencevOpazovalna študija
- Research Site, Durham
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Duke University Medical Center, Durham
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Vključevanje udeležencevFaza 3
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke Cancer Center, Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- in še 1
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Vključevanje udeležencevFaza 2
- Durham VA Medical Center, Durham, NC, Durham
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Vključevanje udeležencevFaza 2
- Durham VA Medical Center, Durham, NC, Durham
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- Duke University Medical Center, Durham
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Vključevanje udeležencevFaza 3
- Duke University Medical Center, Durham
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Vključevanje udeležencevFaza 3
- Durham VA Medical Center, Durham
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Vključevanje udeležencevOpazovalna študija
- Duke University, Durham
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- Duke University Medical Center, Durham
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Vključevanje udeležencevFaza 1/2
- Duke University medical center, Durham
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Duke University, Durham
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Vključevanje udeležencevFaza 2
- Duke University Medical Center - Duke Cancer Center, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- Duke Cancer Institute, Durham
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
Vključevanje udeležencevOpazovalna študija
- Duke University, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Vključevanje udeležencevFaza 1
- Duke Cancer Center, Durham
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Duke University, Durham
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Vključevanje udeležencevVabljeni zdravi prostovoljci
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 mi stran
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Vključevanje udeležencevFaza 4
- Duke University Medical Center, Durham
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Vključevanje udeležencevOpazovalna študija
- Durham VA Medical Center, Durham
- Duke Cancer Network, Durham
- Duke University, Durham
- in še 1
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Vključevanje udeležencevFaza 2/3
- Durham VA Medical Center, Durham, NC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Vključevanje udeležencevFaza 1
- Duke Cancer Institute, Durham
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Vključevanje udeležencevFaza 1
- Duke Cancer Center, Durham
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Vključevanje udeležencev
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi stran
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Vključevanje udeležencevOpazovalna študija
- Duke University Medical Center, Durham
Študije za Rak prostate v drugih mestih
- New York City, NY103 študij
- Houston, TX76 študij
- Los Angeles, CA61 študij
- Boston, MA59 študij
- St. Louis, MO46 študij
- Chicago, IL45 študij
- San Francisco, CA45 študij
- Philadelphia, PA44 študij
- Baltimore, MD43 študij
- Nashville, TN43 študij
- Seattle, WA42 študij
- Washington, DC38 študij
Druge študije v Durham
- Rak dojke64 študij
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak39 študij
- Množni mielom37 študij
- Akutna mieločna levkemija33 študij
- Metastatski rak33 študij
- Rak pljuč32 študij
- Kolorektalni rak28 študij
- Rak jajčnikov27 študij
- Kronična limfocitna levkemija27 študij
- Srčno popuščanje26 študij
- Rak trebušne slinavke24 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.